Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

Clinical Trial ID NCT02641093

PubWeight™ 2.32‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02641093

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
2 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
3 PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report. J Immunother Cancer 2016 0.75
Next 100